Key Dates

Related Announcements

RFA-DA-21-009 - Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform applicants of a change to the late application policy for RFA-DA-21-009 “Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 Clinical Trial Optional)”.

This RFA is modified to no longer state, “No late applications will be accepted for this Funding Opportunity Announcement.”

For the October 19, 2020 application due date, NIH Policy on Late Submission of Grant Applications NOT-OD-15-039 applies. Late applications must be accompanied by a cover letter that explains the reasons for late submission. The cover letter may cite this Notice (NOT-DA-20-080) but is not required to do so.

Application Due Date

October 19, 2020

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Belinda E Sims, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1533
Email: bsims@nida.nih.gov